vs
DYNAVAX TECHNOLOGIES CORP（DVAX）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是DYNAVAX TECHNOLOGIES CORP的1.2倍（$117.7M vs $94.9M），DYNAVAX TECHNOLOGIES CORP净利率更高（28.4% vs -1.5%，领先29.8%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $32.6M）
Dynavax Technologies Corp是一家处于商业化阶段的生物制药企业，专注于研发和生产针对传染病的创新疫苗及免疫疗法，核心上市产品为成人乙肝疫苗Heplisav-B，主要市场覆盖北美与欧洲，同时拥有多款针对未满足公共卫生需求的在研产品。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
DVAX vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.2倍
$94.9M
净利率更高
DVAX
高出29.8%
-1.5%
自由现金流更多
RHLD
多$156.6M
$32.6M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.9M | $117.7M |
| 净利润 | $26.9M | $-1.7M |
| 毛利率 | — | 55.7% |
| 营业利润率 | 22.4% | 30.2% |
| 净利率 | 28.4% | -1.5% |
| 营收同比 | 17.7% | — |
| 净利润同比 | 53.0% | — |
| 每股收益（稀释后） | $0.21 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DVAXRHLD
| Q4 25 | — | $117.7M | ||
| Q3 25 | $94.9M | $120.9M | ||
| Q2 25 | $95.4M | $119.6M | ||
| Q1 25 | $68.2M | $103.9M | ||
| Q4 24 | $72.0M | — | ||
| Q3 24 | $80.6M | — | ||
| Q2 24 | $73.8M | — | ||
| Q1 24 | $50.8M | — |
净利润DVAXRHLD
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $26.9M | $-231.0K | ||
| Q2 25 | $18.7M | $-611.0K | ||
| Q1 25 | $-96.1M | $-3.4M | ||
| Q4 24 | $7.0M | — | ||
| Q3 24 | $17.6M | — | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $-8.7M | — |
毛利率DVAXRHLD
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | — | 52.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率DVAXRHLD
| Q4 25 | — | 30.2% | ||
| Q3 25 | 22.4% | 34.3% | ||
| Q2 25 | 15.1% | 34.0% | ||
| Q1 25 | -34.7% | 24.7% | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 12.5% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | -35.0% | — |
净利率DVAXRHLD
| Q4 25 | — | -1.5% | ||
| Q3 25 | 28.4% | -0.2% | ||
| Q2 25 | 19.6% | -0.5% | ||
| Q1 25 | -141.0% | -3.2% | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 15.4% | — | ||
| Q1 24 | -17.2% | — |
每股收益（稀释后）DVAXRHLD
| Q4 25 | — | $-0.20 | ||
| Q3 25 | $0.21 | $-0.03 | ||
| Q2 25 | $0.14 | $-0.07 | ||
| Q1 25 | $-0.77 | $-0.39 | ||
| Q4 24 | $0.07 | — | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $0.08 | — | ||
| Q1 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $534.1M | $6.5M |
| 总资产 | $946.5M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资DVAXRHLD
| Q4 25 | — | $205.5M | ||
| Q3 25 | $160.2M | $148.0M | ||
| Q2 25 | $99.1M | $99.9M | ||
| Q1 25 | $51.7M | $71.0M | ||
| Q4 24 | $95.9M | — | ||
| Q3 24 | $119.3M | — | ||
| Q2 24 | $112.5M | — | ||
| Q1 24 | $132.0M | — |
总债务DVAXRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DVAXRHLD
| Q4 25 | — | $6.5M | ||
| Q3 25 | $534.1M | $10.8M | ||
| Q2 25 | $494.2M | $9.6M | ||
| Q1 25 | $530.9M | $8.9M | ||
| Q4 24 | $596.8M | — | ||
| Q3 24 | $681.4M | — | ||
| Q2 24 | $642.8M | — | ||
| Q1 24 | $618.5M | — |
总资产DVAXRHLD
| Q4 25 | — | $333.4M | ||
| Q3 25 | $946.5M | $293.2M | ||
| Q2 25 | $918.4M | $253.3M | ||
| Q1 25 | $945.9M | $214.3M | ||
| Q4 24 | $986.3M | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $986.6M | — |
负债/权益比DVAXRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.8M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $32.6M | $189.2M |
| 自由现金流率自由现金流/营收 | 34.4% | 160.8% |
| 资本支出强度资本支出/营收 | 1.3% | 5.8% |
| 现金转化率经营现金流/净利润 | 1.26× | — |
| 过去12个月自由现金流最近4个季度 | $80.5M | $313.2M |
8季度趋势，按日历期对齐
经营现金流DVAXRHLD
| Q4 25 | — | $196.1M | ||
| Q3 25 | $33.8M | $59.6M | ||
| Q2 25 | $23.4M | $48.9M | ||
| Q1 25 | $-19.6M | $18.4M | ||
| Q4 24 | $53.0M | — | ||
| Q3 24 | $19.5M | — | ||
| Q2 24 | $10.7M | — | ||
| Q1 24 | $-16.7M | — |
自由现金流DVAXRHLD
| Q4 25 | — | $189.2M | ||
| Q3 25 | $32.6M | $58.6M | ||
| Q2 25 | $22.0M | $47.5M | ||
| Q1 25 | $-23.6M | $17.8M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $18.1M | — | ||
| Q2 24 | $9.9M | — | ||
| Q1 24 | $-17.4M | — |
自由现金流率DVAXRHLD
| Q4 25 | — | 160.8% | ||
| Q3 25 | 34.4% | 48.5% | ||
| Q2 25 | 23.0% | 39.7% | ||
| Q1 25 | -34.6% | 17.1% | ||
| Q4 24 | 68.8% | — | ||
| Q3 24 | 22.5% | — | ||
| Q2 24 | 13.5% | — | ||
| Q1 24 | -34.3% | — |
资本支出强度DVAXRHLD
| Q4 25 | — | 5.8% | ||
| Q3 25 | 1.3% | 0.8% | ||
| Q2 25 | 1.5% | 1.2% | ||
| Q1 25 | 5.8% | 0.6% | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.5% | — |
现金转化率DVAXRHLD
| Q4 25 | — | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
RHLD
暂无分部数据
